MedPath

Home Pregnancy Test Evaluation Study

Not Applicable
Completed
Conditions
Pregnancy Testing
Interventions
Diagnostic Test: home pregnancy test
Registration Number
NCT03589534
Lead Sponsor
SPD Development Company Limited
Brief Summary

This study will evaluate consumer preference and consumer results from a number of commercially available home pregnancy tests.

The study is being conducted as a formal assessment home pregnancy tests sold in Western Europe.

Detailed Description

The study will be conducted in two parts:

Part 1: Volunteers representative of pregnancy test users will use a range (4 of 7 different tests being evaluated) in their own home to gain usability data. All products will be used according to their instructions for use which, where required, will be translated into English prior to the study start. A study questionnaire will be completed after each test is used.

Part 2: The volunteers will attend the study site soon after completing their last home test and be required to read randomised results of tests conducted by study technicians (pregnant and not pregnant) to gain an understanding of their ability to correctly read results of the tests. The technician will also read and record the test results to enable both the laboratory agreement (technician read) and the consumer readability to be determined and compared for each product.

Each volunteer will be required to provide a urine sample for determining pregnancy status and quantitative urinary hormone measurement (this is done to confirm the result obtained at home using the HPTs).

At the end of the testing period the volunteers will also be asked to rank the four products they have used in the study, based on a series of statements regarding usability and readability of the tests

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
250
Inclusion Criteria
  • Female
  • Aged 18-45 years
  • Willing to give informed consent
  • Willing to conduct a personal home pregnancy test and reveal their pregnancy status
Exclusion Criteria
  • Currently or previously employed by SPD, Alere, Unipath, P&G, Abbott, or affiliates
  • Has an immediate relative* currently or previously employed by SPD, Alere, Unipath, P&G, Abbott or affiliates
  • Taken a hormonal preparation containing hCG in the last month, e.g. Pregnyl®
  • Recently miscarried and yet to have 2 complete menstrual cycles before study start

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
pregnancy testhome pregnancy testpregnancy tests
Primary Outcome Measures
NameTimeMethod
3. Demonstration of consumer preference for a HPT1 week

• The ranking of each Home Pregnancy Test in order of preference

2. Demonstration of volunteer readability of HPTs1 week

• The cumulative scores on a 7-point likert scale for readability questions on the device readability at SPD questionnaire, where 1 equals very easy and 7 equals very difficult for each attribute.

1. Demonstration of volunteer preference for a HPTs.1 week

• The cumulative scores on a 7-point likert scale for ease of use questions on the device usability at home questionnaire, where 1 equals very good and 7 equals very poor for each attribute.

Secondary Outcome Measures
NameTimeMethod
Agreement of reading1 week

The agreement between volunteer home pregnancy test results and those of a technician testing the same urine standard (volunteer vs. technician test result)

1. Accuracy of reading1 week

The per cent agreement (accuracy) between the result read by the volunteer and true result for each standard tested (i.e 0 hCG will be not pregnant and 25mIU/ml hCG will be pregnant) for each Home pregnancy test evaluated.

Trial Locations

Locations (1)

SPD Development Company Ltd.

🇬🇧

Bedford, Bedfordshire, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath